One study that examined translocated microbial products and their ability to predict cirrhosis and progression to end-stage liver disease in HCV and HBV infection found elevated plasma levels of LPS, IFABP, IL-6, and sCD14 in patients with HCV or HBV compared to uninfected controls [3]. The gene discussed is IL6; the disease is End Stage Liver Disease.